UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. However, I rate it as a Buy. The company's long-term EPS growth target of 13-16% is achievable, supported by the company's strong track record. UNH's current valuation is attractive, trading at a P/E ratio that aligns with historical trends, suggesting potential for double-digit annual returns based on expected EPS growth.
Sarah James, Cantor Fitzgerald, joins 'Fast Money' to talk how she is playing UnitedHealth's stock right now.
Jay Hatfield, Infra-Cap CEO, joins 'Power Lunch' to discuss stock plays for three stocks.
UNH's third-quarter earnings benefit on the back of client wins in the Optum Rx sub-unit, partly offset by an elevated operating expense level.
Shares of UnitedHealth Group (UNH) tumbled Tuesday after the company lowered its full-year profit outlook to reflect the impact of a cyberattack against its Change Healthcare division in February.
UnitedHealth Group Incorporated (NYSE:UNH ) Q3 2024 Earnings Conference Call October 15, 2024 8:45 AM ET Company Participants Andrew Witty - CEO John Rex - President and CFO Tim Noel - CEO, UnitedHealthcare Medicare & Retirement Amar Desai - CEO, Optum Health Roger Connor - CEO, Optum Insight Brian Thompson - CEO, UnitedHealthcare Heather Cianfrocco - CEO, Optum Dan Kueter - CEO, UnitedHealthcare of Employer & Individual Patrick Conway - CEO OptumRx Conference Call Participants Lisa Gill - JPMorgan A.J. Rice - UBS Stephen Baxter - Wells Fargo Josh Raskin - Nephron Research Scott Fidel - Stephens Justin Lake - Wolfe Research Sarah James - Cantor Fitzgerald Lance Wilkes - Bernstein Erin Wright - Morgan Stanley Andrew Mok - Barclays Operator Good morning, and welcome to the UnitedHealth Group's Third Quarter 2024 Earnings Conference Call.
Cyberattacks can have a deceptively longtail impact, as UnitedHealth's Tuesday (Oct. 15) earnings call revealed. In February 2024, UnitedHealth Group Inc.'s Change Healthcare unit suffered a far-reaching cyberattack.
Medical costs continue to surge more than expected for health insurers.
While the top- and bottom-line numbers for UnitedHealth (UNH) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The company estimates that its formal guidance for 2025 will top out at about $30 in earnings per share
UnitedHealth (UNH) gave back all its gains from the past three months following its earnings miss and narrowed EPS guidance. Meanwhile, Walgreens (WBA) rallied after announcing more than a thousand store closures.
UnitedHealth Group (UNH) came out with quarterly earnings of $7.15 per share, beating the Zacks Consensus Estimate of $7.02 per share. This compares to earnings of $6.56 per share a year ago.